drugset / Trial / NCT02080767

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

NCT02080767 ↗

Summary

The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tecovirimat Small molecule 600 mg Oral

Indications